Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124803433 | 12480343 | 3 | F | 20160622 | 20160620 | 20160707 | EXP | JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-118743 | RANBAXY | 50.00 | YR | F | Y | 0.00000 | 20160707 | OT | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124803433 | 12480343 | 1 | PS | VALPROIC ACID. | VALPROIC ACID | 1 | Unknown | 200 MG, DAILY | 91037 | 200 | MG | ||||||||
| 124803433 | 12480343 | 2 | I | VALPROIC ACID. | VALPROIC ACID | 1 | Unknown | 1000 MG, DAILY | Y | 91037 | 1000 | MG | |||||||
| 124803433 | 12480343 | 3 | SS | OLANZAPINE. | OLANZAPINE | 1 | Unknown | 10 MG, DAILY | 0 | 10 | MG | ||||||||
| 124803433 | 12480343 | 4 | SS | OLANZAPINE. | OLANZAPINE | 1 | Unknown | 20 MG, DAILY | 0 | 20 | MG | ||||||||
| 124803433 | 12480343 | 5 | SS | QUETIAPINE. | QUETIAPINE | 1 | Unknown | 200 MG, DAILY | 0 | 200 | MG | ||||||||
| 124803433 | 12480343 | 6 | I | PALIPERIDONE. | PALIPERIDONE | 1 | Unknown | UNK | 0 | ||||||||||
| 124803433 | 12480343 | 7 | I | PALIPERIDONE. | PALIPERIDONE | 1 | Unknown | OVER 2 WEEKS | Y | U | 0 | 12 | MG | ||||||
| 124803433 | 12480343 | 8 | SS | LITHIUM. | LITHIUM | 1 | Unknown | 200 MG, DAILY | Y | U | 0 | 200 | MG | ||||||
| 124803433 | 12480343 | 9 | SS | LITHIUM. | LITHIUM | 1 | Unknown | GRADUALLY DECREASED AND STOPPED | Y | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124803433 | 12480343 | 1 | Psychotic disorder |
| 124803433 | 12480343 | 2 | Psychotic disorder |
| 124803433 | 12480343 | 3 | Psychotic disorder |
| 124803433 | 12480343 | 4 | Psychotic disorder |
| 124803433 | 12480343 | 5 | Psychotic disorder |
| 124803433 | 12480343 | 6 | Psychotic disorder |
| 124803433 | 12480343 | 7 | Psychotic disorder |
| 124803433 | 12480343 | 8 | Psychotic disorder |
| 124803433 | 12480343 | 9 | Psychotic disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124803433 | 12480343 | OT |
| 124803433 | 12480343 | HO |
| 124803433 | 12480343 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124803433 | 12480343 | Drug ineffective | |
| 124803433 | 12480343 | Drug interaction | |
| 124803433 | 12480343 | Leukopenia | |
| 124803433 | 12480343 | Neutropenia | |
| 124803433 | 12480343 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |